The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover

Featured
Interviews

Eye on China

Columns

Conferences ListingConferences
Listing

e-alerts
Pharma Sales
EYE ON CHINA
Simulations Plus signs new partnership agreement in China

Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, has signed a distributor agreement with the Research Institute for Liver Diseases (RILD) in Shanghai, People's Republic of China.

Mr. John DiBella, vice president for marketing and sales for Simulations Plus, said, "We're very pleased to be working with the RILD to offer in silico consulting services using our various software programs in support of RILD's in vitro experimental systems to its customers in China. Dr. Zhuohan Hu, President and CEO of RILD, is highly respected within the pharmaceutical industry in China, and we look forward to leveraging his connections with researchers at regulatory agencies and local companies to continue penetrating this growing market. We expect this new dealership to help promote our consulting services in the areas of drug absorption, toxicity, metabolism, and drug-drug interactions."

Source: Business Wire

Click here for the complete issue.